| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR | RVI BIOTECNOLOGÍA | 33,680000 | 29/06/2026 | 18,80% | 97,31% | ***** |
| ROBECO QI EMERGING MARKETS ACTIVE EQUITIES D EUR | RVI EMERGENTES | 416,770000 | 29/06/2026 | 32,62% | 97,15% | ***** |
| COBAS INTERNACIONAL, FI D | RVI GLOBAL VALOR | 293,240831 | 29/06/2026 | 15,74% | 97,07% | ***** |
| PRIVILEDGE - ALPHA JAPAN (CHF) P CAP SYST. HDG | RVI JAPÓN | 51,674875 | 26/06/2026 | 16,03% | 96,53% | ***** |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR HEDGED | RVI BIOTECNOLOGÍA | 38,390000 | 29/06/2026 | 15,04% | 96,37% | ***** |
| ALKEN FUND - EUROPEAN OPPORTUNITIES US1 | RVI EUROPA | 281,860424 | 29/06/2026 | 2,76% | 96,36% | ***** |
| DWS INVEST II GLOBAL EQUITY HIGH CONVICTION LC | RVI GLOBAL | 505,060000 | 29/06/2026 | 27,99% | 96,32% | ***** |
| AXA IM GLOBAL EMERGING MARKETS EQUITY QI A USD ACC | RVI EMERGENTES | 31,588638 | 29/06/2026 | 29,55% | 96,20% | ***** |
| ROBECO QI EMERGING MARKETS ENHANCED INDEX EQUITIES I USD | RVI EMERGENTES | 248,605997 | 29/06/2026 | 28,96% | 96,11% | ***** |
| ISHARES MSCI JAPAN EUR HEDGED UCITS ETF (ACC) | RVI JAPÓN | 140,998400 | 29/06/2026 | 19,72% | 96,02% | ***** |
